Although the activation of the IL-6/STAT3 signal has been primarily identified as being necessary for the proliferation of several types of CSCs, tumor-derived erythropoietin, mainly released under hypoxic conditions, also activates the JAK2–STAT3 axis in breast CSCs and promotes self-renewal [100]. The gene discussed is STAT3; the disease is neoplasm.